This brand name is authorized in Canada, Cyprus, Ecuador, Estonia, Finland, France, Croatia, Israel, Italy, Japan, Lithuania, New Zealand, Poland, Romania, Tunisia, United States
The drug MEDROL contains one active pharmaceutical ingredient (API):
1
Methylprednisolone
UNII X4W7ZR7023 - METHYLPREDNISOLONE
|
Methylprednisolone is a synthetic glucocorticoid and a methyl derivative of prednisolone. Methylprednisolone is a potent anti-inflammatory agent with the capacity to profoundly inhibit the immune system. |
Below package inserts are available for further reading:
Title | Information Source | Document Type | |
---|---|---|---|
MEDROL Tablet | FDA, National Drug Code (US) | MPI, US: SPL/Old |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
ATC code | Group title | Classification |
---|---|---|
H02AB04 | Methylprednisolone | H Systemic hormonal preparations, excl. Sex hormones and insulins → H02 Corticosteroids for systemic use → H02A CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN → H02AB Glucocorticoids |
This drug has been assigned below unique identifiers within the countries it is being marketed:
Country | Identification scheme | Identifier(s) |
---|---|---|
Country: CA | Health Products and Food Branch | Identifier(s): 00030988, 00036129 |
Country: EC | Agencia Nacional de Regulación, Control y Vigilancia Sanitaria | Identifier(s): 28897-06-09, 28898-06-09 |
Country: EE | Ravimiamet | Identifier(s): 1009077, 1009099, 1065754, 1738324, 1738335, 1866922, 1868328 |
Country: FI | Lääkealan turvallisuus- ja kehittämiskeskus | Identifier(s): 111245, 117729, 139082, 159103, 174284, 453125 |
Country: FR | Base de données publique des médicaments | Identifier(s): 60224316, 60988157, 64639548 |
Country: HR | Agencija za lijekove i medicinske proizvode | Identifier(s): HR-H-123990428, HR-H-251851390, HR-H-371675611 |
Country: IL | מִשְׂרַד הַבְּרִיאוּת | Identifier(s): 84 |
Country: IT | Agenzia del Farmaco | Identifier(s): 014159040 |
Country: JP | 医薬品医療機器総合機構 | Identifier(s): 2456003F1034, 2456003F2030 |
Country: LT | Valstybinė vaistų kontrolės tarnyba | Identifier(s): 1001231, 1001232, 1001233, 1058666, 1058667, 1066055, 1078904 |
Country: NZ | Medicines and Medical Devices Safety Authority | Identifier(s): 4919, 4920 |
Country: PL | Rejestru Produktów Leczniczych | Identifier(s): 100042308, 100042314 |
Country: RO | Agenția Națională a Medicamentului și a Dispozitivelor Medicale | Identifier(s): W65155001, W65156001, W65157001 |
Country: TN | Direction de la Pharmacie et du Médicament | Identifier(s): 6530052, 6530053 |
Country: US | FDA, National Drug Code | Identifier(s): 0009-0020, 0009-0022, 0009-0056, 0009-0073, 0009-0176, 50090-0092 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.